Philippines - English - FDA (Food And Drug Administration)

msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - inactivated porcine circovirus (pcv) virus vaccine (vet.) - emulsion for injection (id) - formulation: each 0.2 ml (dose) contains: porcine circovirus type 2 (orf2)> 1436 au au-antigenic units

Philippines - English - FDA (Food And Drug Administration)

msd animal health (phils.), inc. - inactivated porcine circovirus (pcv) , mesomycoplasma hyopneumoniae vaccine (vet.) - emulsion for injection (im) - formulation: each 1 ml (dose) contains: porcine circovirus, type 2 - orf 2 (wt 2/1 strain) mesomycoplasma hyopneumoniae (j strain) . au - antigenic unit rpu – relative potency unit processed under fda memorandum circular 2021-001. ≥ 1414 au ≥ 2.69 rpu

Philippines - English - FDA (Food And Drug Administration)

nobel vet, inc.; distributor: nobel vet, inc. - inactivated porcine circovirus (pcv) vaccine (vet.) - \suspension for injection (im) - each i ml (dose) contains: porcine circovirus type 2 (pcv2 - orf2 gene).........> 200 protein unit

European Union - English - EMA (European Medicines Agency)

ceva-phylaxia oltóanyagtermelõ zrt. - inactivated porcine circovirus type 2 (pcv2) - immunologicals for suidae - pigs (gilts and sows) - sows and giltspassive immunisation of piglets via the colostrum, after active immunisation of sows and gilts, to reduce lesions in lymphoid tissues associated with pcv2 infection and as an aid to reduce pcv2-linked mortality.pigletsactive immunisation of piglets to reduce faecal excretion of pcv2 and virus load in blood, and as an aid to reduce pcv2-linked clinical signs, including wasting, weight loss and mortality, as well as to reduce virus load and lesions in lymphoid tissues associated with pcv2 infection.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - porcine circovirus recombinant virus (cpcv) 1-2, inactivated - immunologicals - pigs (piglets) - active immunisation of pigs over the age of three weeks against porcine circovirus type 2 (pcv2) to reduce viral load in blood and lymphoid tissues, and the lesions in lymphoid tissues associated with pcv2 infection, as well as to reduce clinical signs - including loss of daily weight gain, and mortality associated with post-weaning multisystemic wasting syndrome.

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - porcine circovirus type 2 orf2 subunit antigen - immunologicals for suidae, inactivated viral vaccines - pigs - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by pcv2 infection. to reduce loss of daily weight gain and mortality associated with pcv2 infection.

New Zealand - English - Ministry for Primary Industries

boehringer ingelheim animal health new zealand limited - porcine circovirus type 2 orf-2 protein - porcine circovirus type 2 orf-2 protein 0 vaccine - vaccine

European Union - English - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunologicals for suidae - pigs (for fattening) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d.active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection. onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination. duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination. in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

Philippines - English - FDA (Food And Drug Administration)

ceva animal health (philippines), inc.; distributor: ceva animal health (philippines), inc. - inactivated porcine circovirus (pcv) vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: porcine circovirus type 2 (pcv2). > 2.1 log^10 elisa units enzyme-linked immunosorbent assay (elisa)

Philippines - English - FDA (Food And Drug Administration)

nobel vet, inc.; distributor: nobel vet, inc. - inactivated recombinant porcine circovirus (pcv) vaccine (vet.) - suspension for injection (im) - formulation: each 1 ml (dose) contains: porcine circovirus type 2 (pcv2 - orf2 gene)........ 100 protein unit